Crossmark

A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies

Crossref DOI link: https://doi.org/10.1007/s40273-016-0464-2

Published Online: 2016-10-27

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wei, Ching-Yun https://orcid.org/0000-0003-4658-9116
Quek, Ruben G. W.

Villa, Guillermo

Gandra, Shravanthi R.

Forbes, Carol A.

Ryder, Steve

Armstrong, Nigel

Deshpande, Sohan

Duffy, Steven

Kleijnen, Jos

Lindgren, Peter
Funding

Funding for this research was provided by:

Amgen (Not applicable)
License Information

License valid from 2016-10-27